Send Message

COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease

Basic Information
Place of Origin: China
Brand Name: ALLTEST
Model Number: ICOV-804
Minimum Order Quantity: N/A
Price: negotiation
Packaging Details: 20T
Delivery Time: 2-4 Weeks
Supply Ability: 10 M tests/month
Product Name: COVID-19 Antigen Rapid Test (Corona Lollipop Rapid Test) (Oral Fluid),infectious Disease Test Principle: Chromatographic Immunoassay
Format: Cassette Specimen: Oral Fluid
Reading Time: 15 Minutes Pack: 20T
Storage Temperature: 2-30°C Shelf Life: 2 Years
Sensitivity: 93.5% Specificity: 99.2%
Accuracy: 97.6% FEATURES 1: Innovative Specimen Collection
FEATURES 2: Fast Results In 15 Minutes FEATURES 3: Simple Visual Interpretation
FEATURES 4: Convenient Operation FEATURES 5: High Accuracy
High Light:

COVID-19 Antigen Rapid Test

,

Oral Fluid Antigen Rapid Test

Product Name: COVID-19 Antigen Rapid Test (Corona Lollipop Rapid Test) (Oral Fluid),infectious Disease Test
Format: Cassette
Reading Time: 15 Minutes
Storage Temperature: 2-30°C
Sensitivity: 93.50%
Accuracy: 97.60%
FEATURES 2: Fast Results In 15 Minutes
FEATURES 4: Convenient Operation
Principle: Chromatographic Immunoassay
Specimen: Oral Fluid
Pack: 20T
Shelf Life: 2 Years
Specificity: 99.20%
FEATURES 1: Innovative Specimen Collection
FEATURES 3: Simple Visual Interpretation
FEATURES 5: High Accuracy

COVID-19 Antigen Rapid Test (Corona Lollipop Rapid Test) (Oral Fluid),infectious disease test

 

Application

 

The COVID-19 Antigen Rapid Test (Corona Lollipop Rapid Test) (Oral Fluid) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in oral fluid specimens from individuals with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.
 
COVID-19 Antigen Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens present in human oral fluid. For professional in vitro diagnostic use only.
 
INTENDED USE
 
Results are for the detection of SARS-CoV-2 nucleocapsid protein antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co-infection with other
viruses. The agent detected may not be the definite cause of disease.
 
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions. Negative results should be treated as presumptive and confirmed with a molecular assay, if necessary for patient management. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19.
 
PRINCIPLE
 
The COVID-19 Antigen Rapid Test (Corona Lollipop Rapid Test) (Oral Fluid) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 nucleocapsid protein antigens in human oral fluid specimen. SARS-CoV-2 nucleocapsid protein antibody is coated in the test line region. During testing, the specimen reacts with SARS-CoV-2 nucleocapsid protein antibody-coated particles in the test. The mixture then migrates upward on the membrane by capillary action and reacts with the SARS-CoV-2 nucleocapsid protein antibody in test line region. If the
specimen contains SARS-CoV-2 antigens, a colored line will appear in test line region as a result of this. If the specimen does not contain antigens to SARS-CoV-2, no colored line will appear in the test line region, indicating a negative result. To serve as a procedural control, a colored line will always appear in the control line region, indicating that the proper volume of specimen has been added and membrane wicking has occurred.
 
DIRECTIONS FOR USE
 
Allow the test device, collection device, buffer and/or controls to equilibrate to room temperature (15-30°C) prior to testing.
 
Specimen Collection
Important: Before collecting oral fluid, instruct the patients not to place anything in the mouth including food, drink, gum or tobacco products for at least 10 minutes prior to collection. Instruct the patients to deeply cough 3-5 times. It is recommended to collect oral fluid after deep coughing in the morning.
COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease 0
 
①Remove the collection device and collect oral fluid specimen.
If there’s not enough oral fluid collected, repeat the above specimen collection steps.
COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease 1
Specimen Extraction
②Mix the buffer with the collected oral fluid. Gently shake or squeeze the tube with the mixture for 10 seconds to mix well.
NOTE: The storage of the specimen after extraction is stable for 2 hours at room temperature or 24 hours at 2-8°C.
 
COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease 2
Test Reaction
Remove the test device from the sealed foil pouch and use it within one hour. Best results will be obtained if the test is performed immediately after opening the foil pouch.
③Add 2 drops of extracted specimen to the test device, Wait for the colored line(s) to appear. Read the result at 15 minutes. Do not interpret the result after 20 minutes.
COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease 3
④After test is completed, place all the components of the test kit in the plastic biosafety bag and dispose according to local regulation. Do not reuse any used components of the kit.
 
SUMMARY
 
The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
 
COVID-19 Antigen Rapid Test Oral Fluid For Infectious Disease 4
 

Concerns are growing over the new variants of the COVID-19 virus, such as EG.5 and BA.2.86. In August, EG.5 emerged as a major variant in the United States, and the World Health Organization classified it as a "variant of interest," indicating that its genetic changes give it an advantage and its prevalence is on the rise. The other new variant that scientists are watching closely is BA.2.86, nicknamed Pirola. Descended from a different Omicron variant, BA.2.86 has been definitively tied to a few dozen cases of COVID-19 across four continents, but experts suspect it is more widespread. Experts point out that the weather conditions during autumn and winter are more favorable for the transmission of the virus. Coupled with a decline in population immunity, the infection situation in the coming months deserves close attention.

 

To prevent the potential surge of infections during the winter season, it is crucial to implement effective preventive measures. Here are some key steps we can take:

 

To effectively defend against COVID-19 variant, it is important to follow key preventive measures. These include widespread vaccination, practicing good hygiene such as regular handwashing and respiratory etiquette, and wearing masks in high-risk settings. Additionally, maintaining physical distance, avoiding crowded places, and staying updated on local guidelines are essential. By adhering to these measures, we can significantly reduce the risk of infection and protect ourselves and others from the spread of COVID-19.

 
 
 

Contact Details
selina

Phone Number : +8615857153722

WhatsApp : +8613989889852